The FDA announced on April 18, 2014, that Hospira Inc. is recalling 1% LIDOCAINE HCl Injection vials due to the presence of iron oxide particulates. The agency classified this Class I recall as voluntary.
How to tell if you have it
- Brand: Hospira
- Product: 1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL Single-dose vials
- Packaging: 25-count cartons
- NDC: 0409-4279-02
- Lot number: 31-427-DK
- Expiration date: 01JUL2015
- Units affected: 120,900 vials
The hazard
The recall addresses confirmed customer complaints of orange and black particulates, identified as iron oxide, found embedded within the glass vial and floating in the solution. The FDA classified this defect as a Class I hazard.
Context
GovInfoNow's records show Hospira Inc. has had 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include American Regent Papaverine HCl Injection (July 24, 2026), Asclemed Lidocaine HCl Injection (June 8, 2026), and Huons Lidocaine HCl Injection (April 2, 2026).